Jefferson University Hospitals

Physician Profile

Marinos Dalakas, MD

Jefferson University Physician

Academic Title: Professor

Neurology - Neuromuscular

Make An Appointment

Click to call 1-800-JEFF-NOW (800-533-3669) or

Office Locations

909 Walnut Street
2nd Floor, COB Bldg.
Philadelphia PA 19107
Phone: (215) 955-7952
Fax: (215) 955-9976

Board Certifications

  • Neurology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital


Director, Neuromuscular Division


  • University of Athens, Greece, Medical School


  • Ellis Hospital, New York


  • University of Medicine & Dentistry of New Jersey


  • National Institute of Health

Recent Publications

Gene therapy for Duchenne muscular dystrophy: Balancing good science, marginal efficacy, high emotions and excessive cost

A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome

Rituximab in anti-MAG neuropathy: More evidence for efficacy and more predictive factors

International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome

Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy

Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease

Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations

Treating myasthenia on consensus guide: Helpful and challenging but still unfinished business

Molecular treatment effects of alemtuzumab in skeletal muscles of patients with IBM

Close to the node but far enough

Viruses in IBM: Hit-and-run, hide and persist, or irrelevant?

Necrotising autoimmune myopathy (NAM): Antibodies seem to be specific markers in aiding diagnosis

The spectrum of inflammatory myopathies: Dermatomyositis, polymyositis, necrotizing myositis, and inclusion-body myositis

Neuro-Immunotherapies: A 30-year Retrospective of an Overwhelming Success and a Brighter Future

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials

Efficacy of Intravenous Immunoglobulin in Neurological Diseases

Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity

Progressive encephalomyelitis with rigidity and myoclonus (PERM): Brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab

Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease